Ignite Creation Date:
2024-05-06 @ 12:06 AM
Last Modification Date:
2024-10-26 @ 10:45 AM
Study NCT ID:
NCT01499069
Status:
COMPLETED
Last Update Posted:
2019-12-02
First Post:
2011-05-24
Brief Title:
Urinary Nerve Growth Factor NGF Prostaglandin E2 PGE2and Adenosine Triphosphate ATP Potential Biomarkers in Overactive Bladder Patients
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Study Overview
Official Title:
Urinary NGF PGE2 and ATP Potential Biomarkers for Diagnosis and Prediction of Treatment Efficacy in Overactive Bladder Patients
Status:
COMPLETED
Status Verified Date:
2019-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Nerve growth factor NGF prostaglandin E2 PGE2and adenosine triphosphate ATP levels in urine were reported to increase in patients with overactive bladder OAB Also administration of the anti-muscarinic agent was reported to decrease urinary NGF and ATP
The investigators aimed to explore the value of the urinary NGF PGE2 and ATP as biomarker for predicting the treatment responsiveness and symptom relapse in OAB patients So the patients can be categorized into responder or non- responder and relapse or non-relapse groups Ultimately they can receive individualized treatments
The investigators aimed to explore the value of the urinary NGF PGE2 and ATP as biomarker for predicting the treatment responsiveness and symptom relapse in OAB patients So the patients can be categorized into responder or non- responder and relapse or non-relapse groups Ultimately they can receive individualized treatments
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None